Multiple bilateral circumscribed breast masses usually benign

September 17, 2013
Multiple bilateral circumscribed breast masses usually benign
Multiple bilateral circumscribed breast masses detected with ultrasound screening are almost always benign, according to research published in the September issue of Radiology.

(HealthDay)—Multiple bilateral (MB) circumscribed breast masses detected with ultrasound screening are almost always benign, according to research published in the September issue of Radiology.

Wendie A. Berg, M.D., Ph.D., from the American College of Radiology Imaging Network in Philadelphia, and colleagues analyzed data from 2,662 participants and 7,473 screening studies at 21 international sites. Ultrasound studies were interpreted with blinding to mammography results. Simple were noted, and features of all other Breast Imaging Reporting and Data System findings were recorded. Biopsy or mammography and ultrasound were used to determine malignancy rates at a minimum of 11 months of follow-up.

The researchers found that, based on the 2,172 participants (from 6,103 screening studies; median age at baseline, 54 years) ultimately included, there were 1,454 unique findings using ultrasound. There were 135 participants (6.2 percent) with 153 unique MB circumscribed breast masses, with no malignancies. In the 1,319 participants with 2,464 non-MB (60.7 percent), there were 1,038 solitary circumscribed masses with a malignancy rate of 0.8 percent. For the 836 solitary circumscribed masses with at least two years of follow-up, the rate was 0.4 percent. More than 60 percent of the 135 women with MB circumscribed masses also had a solitary lesion, with two of these 82 women having cancer.

"We recommend diagnostic follow-up at one year for MB circumscribed benign-appearing masses identified at screening ultrasound, with resumption of screening thereafter if the mass is stable, but we recognize that larger studies need to be performed to document that this is a valid approach," the authors write.

Several authors disclosed financial ties to the imaging industry.

Explore further: Multicenter trial finds BI-RADS 3 breast lesions have low cancer rate

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Multicenter trial finds BI-RADS 3 breast lesions have low cancer rate

August 20, 2013
Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be re-evaluated with imaging in 12 ...

Ultrasound could offer affordable, accessible breast cancer screening

November 27, 2012
Ultrasound screening could be a more affordable and convenient way to detect early breast cancers in women, especially for those in countries where there is little access to mammograms, according to University of Pittsburgh ...

Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident ...

Screening breast ultrasound detects cancers missed on mammography in women with dense breasts

April 18, 2013
Screening breast ultrasound performed after mammography on women with greater than 50% breast density detects an additional 3.4 cancers or high risk lesions per one thousand woman screened, a detection rate just under that ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.